128 related articles for article (PubMed ID: 37224448)
1. Neuromodulator Finesse for Masseter Hypertrophy and Bruxism.
Chiodo MV; Lisiecki JL; Rohrich RJ
Plast Reconstr Surg; 2024 Apr; 153(4):726e-729e. PubMed ID: 37224448
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Electromyographic Changes in a Patient with Masseter Hypertrophy and Muscle Pain after Botulinum Injections: A Case Report and 5 Months Follow-up.
Bianco E; Tagliabue R; Mirabelli L; Maddalone M
J Contemp Dent Pract; 2022 Feb; 23(2):226-231. PubMed ID: 35748454
[TBL] [Abstract][Full Text] [Related]
3. [Hypertrophy of the masseter muscle. Clinical aspects--etiology--therapy].
Abrams J
Laryngorhinootologie; 1989 Jul; 68(7):383-7. PubMed ID: 2669773
[TBL] [Abstract][Full Text] [Related]
4. Recurrent parotid swelling secondary to masseter muscle hypertrophy: a multidisciplinary diagnostic and therapeutic approach.
Capaccio P; Gaffuri M; Pignataro L; Assandri F; Pereira P; Farronato G
Cranio; 2016 Nov; 34(6):388-394. PubMed ID: 26892838
[TBL] [Abstract][Full Text] [Related]
5. Clinical investigation of botulinum toxin (prabotulinumtoxin A) for bruxism related to masseter muscle hypertrophy: A prospective study.
Jung BK; Park H; Cheon YW; Yun IS; Choi JW; Kim HJ; Lee MY; Kang BS; Kang TJ
J Craniomaxillofac Surg; 2023 May; 51(5):332-337. PubMed ID: 37353404
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects.
Quezada-Gaon N; Wortsman X; Peñaloza O; Carrasco JE
J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
[TBL] [Abstract][Full Text] [Related]
8. Painful unilateral temporalis muscle enlargement: reactive masticatory muscle hypertrophy.
Katsetos CD; Bianchi MA; Jaffery F; Koutzaki S; Zarella M; Slater R
Head Neck Pathol; 2014 Jun; 8(2):187-93. PubMed ID: 23900775
[TBL] [Abstract][Full Text] [Related]
9. Literature review of the adverse events associated with botulinum toxin injection for the masseter muscle hypertrophy.
Yeh YT; Peng JH; Peng HP
J Cosmet Dermatol; 2018 Oct; 17(5):675-687. PubMed ID: 30091170
[TBL] [Abstract][Full Text] [Related]
10. Temporal volume increase after reduction of masseteric hypertrophy utilizing incobotulinumtoxin type A.
Nikolis A; Enright KM; Rudolph C; Cotofana S
J Cosmet Dermatol; 2020 Jun; 19(6):1294-1300. PubMed ID: 32338450
[TBL] [Abstract][Full Text] [Related]
11. [Asymmetric hypertrophy of the masticatory muscles].
Arzul L; Corre P; Khonsari RH; Mercier JM; Piot B
Ann Chir Plast Esthet; 2012 Jun; 57(3):286-91. PubMed ID: 22455902
[TBL] [Abstract][Full Text] [Related]
12. Complications of botulinum toxin injection for masseter hypertrophy: Incidence rate from 2036 treatments and summary of causes and preventions.
Peng HP; Peng JH
J Cosmet Dermatol; 2018 Feb; 17(1):33-38. PubMed ID: 29250900
[TBL] [Abstract][Full Text] [Related]
13. Benign masseter muscle hypertrophy.
Rispoli DZ; Camargo PM; Pires JL; Fonseca VR; Mandelli KK; Pereira MAC
Braz J Otorhinolaryngol; 2008; 74(5):790-793. PubMed ID: 19082365
[TBL] [Abstract][Full Text] [Related]
14. Changes in the temporomandibular joint disc and temporal and masseter muscles secondary to bruxism in Turkish patients.
Garip H; Tufekcioglu S; Kaya E
Saudi Med J; 2018 Jan; 39(1):81-85. PubMed ID: 29332113
[TBL] [Abstract][Full Text] [Related]
15. Mandibular angle resection and masticatory muscle hypertrophy - a technical note and morphological optimization.
Andreishchev AR; Nicot R; Ferri J
Rev Stomatol Chir Maxillofac Chir Orale; 2014 Nov; 115(5):301-7. PubMed ID: 25001550
[TBL] [Abstract][Full Text] [Related]
16. Management of bilateral masseter muscle hypertrophy.
Özkan BT; Tabrizi R; Cigerim L
J Craniofac Surg; 2012 Jan; 23(1):e14-6. PubMed ID: 22337448
[TBL] [Abstract][Full Text] [Related]
17. A Cadaveric Study of Dye Spreading: Determining the Ideal Injection Pattern for Masseter Hypertrophy.
Sermswan P; Tansatit T; Meevassana J; Panchaprateep R
Dermatol Surg; 2021 Oct; 47(10):1354-1358. PubMed ID: 34417381
[TBL] [Abstract][Full Text] [Related]
18. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
[TBL] [Abstract][Full Text] [Related]
19. The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review.
Almukhtar RM; Fabi SG
Plast Reconstr Surg; 2019 Jan; 143(1):39e-48e. PubMed ID: 30303926
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring.
Kundu N; Kothari R; Shah N; Sandhu S; Tripathy DM; Galadari H; Gold MH; Goldman MP; Kassir M; Schepler H; Grabbe S; Goldust M
J Cosmet Dermatol; 2022 May; 21(5):1849-1856. PubMed ID: 35176198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
